Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ABEONA THERAPEUTICS INC. (ABEO)

Abeona Therapeutics furnishes updated investor presentation for H.C. Wainwright conference

Neutral Impact 1 of 5 other Written later

Abeona Therapeutics furnished an updated investor presentation under Regulation FD, which it expects to use on September 15, 2026 at the H.C. Wainwright 28th Annual Global Investment Conference. The filing is a routine disclosure of presentation materials and reports no financial results, guidance, or transactions.

Key points

  • Updated investor presentation furnished as Exhibit 99.1, dated September 15, 2026
  • Presentation to be used at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026
  • Filing contains no financial results, guidance, or new transactions; signed by CFO Joseph Vazzano

The filing

CompanyABEONA THERAPEUTICS INC. (ABEO)
Form8-K, current report
Filed with the SECSep 15, 2026, 12:00 PM ET
Accession number0001493152-26-042702

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.